GlassScriptPhysician profile
Mary N Smith
NPI 1326239575
$391.04
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2020: $51.51 · 2021: $17.41.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $97.74 | 2019-2020 | |
| Renovia INC | $96.62 | 2019 | |
| Therapeuticsmd, INC. | $64.19 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $43.36 | 2019 | |
| Vertical Pharmaceuticals, LLC | $20.55 | 2019 | |
| Pfizer INC. | $17.41 | 2021 | |
| Coopersurgical, INC. | $13.64 | 2020 | |
| Avion Pharmaceuticals | $13.64 | 2019 | |
| Hologic Sales and Service, LLC | $12.91 | 2019 | |
| Mission Pharmacal Company | $10.98 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.